It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2010.
2010 | Hyderabad, Telangana, India | ActiveAbs-Novacell Biopharmaceuticals Private Limited, a active private limited company, was established on 23 March 2010 in Hyderabad, Telangana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232TG2010PTC067653. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹0.93 M.
Its leadership includes Geetha Kumar Merakanapalli (Director), Niranjan Kumar (Director). Past directors included Madhavan Puthiyaveethil Narayanan Nair. Its latest AGM occurred on 29 September 2012, with the balance sheet filed on 31 March 2012. It is based at 7-125/A, Flat No.502/B, Imperial Prestige Aprts, Leelanagar, Ameerpet,, Hyderabad, Telangana, 500016.
U24232TG2010PTC067653
067653
23 March 2010
₹1.00 Cr
₹0.93 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Abs-Novacell Biopharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Geetha Kumar Merakanapalli | Director | 01 Apr 2013 | Current |
| Niranjan Kumar | Director | 23 Mar 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Abs-Novacell Biopharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Abs-Novacell Biopharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Abs-Novacell Biopharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Abs-Novacell Biopharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abs-Novacell Biopharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Geetha Kumar Merakanapalli was appointed as a Director was appointed as a Director on 01 Apr 2013 & has been associated with this company since 12 years 8 months . was completed.
The activity Abs-Novacell Biopharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2012 as per latest MCA records. was completed.
Progress on Abs-Novacell Biopharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2012 with Roc Hyderabad. was documented.
Niranjan Kumar was appointed as a Director was appointed as a Director on 23 Mar 2010 & has been associated with this company since 15 years 8 months . was recorded as a recent event.
Abs-Novacell Biopharmaceuticals Private Limited was registered on 23 Mar 2010 with Roc Hyderabad & aged 15 years 8 months as per MCA records. was recorded as a recent event.
The CIN of Abs-Novacell Biopharmaceuticals Private Limited is U24232TG2010PTC067653.
Abs-Novacell Biopharmaceuticals Private Limited is headquartered at 7-125/A, Flat No.502/B, Imperial Prestige Aprts, Leelanagar, Ameerpet,, Hyderabad, Telangana, 500016.
Abs-Novacell Biopharmaceuticals Private Limited was incorporated on 23 March 2010.
The current directors of Abs-Novacell Biopharmaceuticals Private Limited are
The primary industry of Abs-Novacell Biopharmaceuticals Private Limited is Chemicals.
Abs-Novacell Biopharmaceuticals Private Limited is unlisted.
The authorized capital of Abs-Novacell Biopharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹0.93 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX